Format

Send to:

Choose Destination
See comment in PubMed Commons below
Best Pract Res Clin Obstet Gynaecol. 2007 Oct;21(5):857-68. Epub 2007 Apr 25.

Preterm labour. The present and future of tocolysis.

Author information

  • 1Faculty of Health, University of Newcastle, Australia. warwick.giles@hnehealth.nsw.gov.au

Abstract

This chapter discusses the tocolytic agents currently in use for the treatment of preterm labour and considers them in light of the evidence base. These agents are the beta2 sympathomimetic agonists, magnesium sulphate (MgSO(4)), indomethacin, nifedipine and atosiban. The available evidence for these agents shows that the beta2 agents are effective but have significant maternal side effects and no effect on perinatal outcome. MgSO(4) and glyceryl trinitrate are clearly ineffective. Nifedipine is effective with a low maternal side effect profile and is associated with improved perinatal outcomes. Meta-analyses of the several randomized controlled trials of atosiban show that it is no more effective than other tocolytic therapies. Possible directions for the future will be discussed.

PMID:
17459777
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk